Evidence map›Paper›PMID 33916347›Full record

ArticleBiology2021

Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities.

Jae Hoon Chung, Minsu Park, Hyun Cho, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Hyun Moo Lee and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jae Hoon ChungSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.ORCID 0000-0002-9729-3457
Minsu ParkDepartment of Statistics, Keimyung University, Daegu 42403, Korea.ORCID 0000-0002-0624-5215
Hyun ChoStatistics and Data Center, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul 06351, Korea.
Wan SongSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Minyong KangSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Hyun Hwan SungSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Hwang Gyun JeonSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Byong Chang JeongSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Seong Il SeoSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Hyun Moo LeeSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.
Seong Soo JeonSamsung Medical Center, Department of Urology, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is controversy over the usefulness of prostate-specific antigen (PSA) as a prostate cancer (PCa) biomarker. This controversy arises when there are differences in the results of PSA assay modalities. In this study, which aimed to evaluate a proper validation between the two PSA assay modalities, the agreement between the results of the two modalities was analyzed. PSA examinations were conducted using two PSA assay modalities in 4810 patients. The intra-class correlation coefficient (ICC) and weighted kappa analysis were used to evaluate the agreement between the two assay modalities. A linear regression was performed to evaluate the association between the two assay modalities. According to ICC values (ICC: 0.999,

Indexed as

diagnosisprostate-specific antigenstatistics

Identifiers

PMID33916347
PMCPMC8065834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.